By Regulatory Approvals — FDA Approves Pluvicto for PSMA+ mAPMN/S Prostate Cancer Oncology Nursing News
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 1, 2026.